Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?

Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.

Neurobiology of disease·2015

Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics.

Neurobiology of aging·2013

Dissociation of p75 receptors and nerve growth factor neurotrophic effects: lack of p75 immunoreactivity in striatum following physical trauma, excitotoxicity and NGF administration.

Restorative neurology and neuroscience·2011

The blood-brain barrier as a target for pharmacological modulation.

Current opinion in drug discovery & development·2009

Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.

Neuro-oncology·2001

The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.

Clinical pharmacokinetics·2001

Hospital-Initiated Guardianship for Older Adults: A Retrospective Analysis.

Journal of the American Geriatrics Society·2026

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV.

Journal of the American Geriatrics Society·2026

Accounting for Competing Events in Longitudinal Studies of Geriatric Outcomes.

Journal of the American Geriatrics Society·2026

Communicating the Geriatrician's Brand in Age-Friendly Care.

Journal of the American Geriatrics Society·2026

Assessing the Effects of Hurricane Hazards on Hospitalization or Death Among Older Adults Using Electricity-Dependent Medical Devices.

Journal of the American Geriatrics Society·2026

Re-Evaluating Predictive Performance in the Clinical Risk Analysis Index of Frailty.

Journal of the American Geriatrics Society·2026

The PHLPP paradox revisited: from canonical AKT phosphatases to signaling pseudoenzymes in human disease.

Biochemical pharmacology·2026

Pironetin Preferentially Inhibits Microtubule Minus-End Growth and Enables Polarity Marking.

Biochemistry. Biokhimiia·2026

Deciphering the therapeutic mechanisms of Pluchea lanceolata in Rheumatoid arthritis (RA) using network pharmacology, molecular docking and in silico molecular dynamics simulations.

In silico pharmacology·2026

PepRePs: Peptide-Retargeted Phosphatases Designed with Generative Language Models.

bioRxiv : the preprint server for biology·2026

Centanafadine: First Approval.

Drugs·2026

Reciprocal blockade of the opioid and D2-like dopamine receptors in the nucleus accumbens modulates the pain-related behaviors in an animal model of inflammatory pain.

Behavioural pharmacology·2026

Related Experiment Videos

Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?

Related Concept Videos

Post-mortem assessment of the short and long-term effects of the trophic factor neurturin in patients with α-synucleinopathies.

Memory deficits in aged cebus monkeys and facilitation with central cholinomimetics.

Dissociation of p75 receptors and nerve growth factor neurotrophic effects: lack of p75 immunoreactivity in striatum following physical trauma, excitotoxicity and NGF administration.

The blood-brain barrier as a target for pharmacological modulation.

Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.

The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.

Hospital-Initiated Guardianship for Older Adults: A Retrospective Analysis.

Frailty Is Associated With Lower Urinary Tract Symptoms in Adults With and Without HIV.

Accounting for Competing Events in Longitudinal Studies of Geriatric Outcomes.

Communicating the Geriatrician's Brand in Age-Friendly Care.

Assessing the Effects of Hurricane Hazards on Hospitalization or Death Among Older Adults Using Electricity-Dependent Medical Devices.

Re-Evaluating Predictive Performance in the Clinical Risk Analysis Index of Frailty.

The PHLPP paradox revisited: from canonical AKT phosphatases to signaling pseudoenzymes in human disease.

Pironetin Preferentially Inhibits Microtubule Minus-End Growth and Enables Polarity Marking.

Deciphering the therapeutic mechanisms of Pluchea lanceolata in Rheumatoid arthritis (RA) using network pharmacology, molecular docking and in silico molecular dynamics simulations.

PepRePs: Peptide-Retargeted Phosphatases Designed with Generative Language Models.

Centanafadine: First Approval.

Reciprocal blockade of the opioid and D2-like dopamine receptors in the nucleus accumbens modulates the pain-related behaviors in an animal model of inflammatory pain.

Related Experiment Videos

Drugs to treat age-related neurodegenerative problems. The final frontier of medical science?

Related Concept Videos

Related Articles